Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Rxulti“
Suchtreffer
Begriffe & Kennungen
Rxulti · 4.8 · 11 In the long-term, open-label trial, the percentage of subjects with clinically significant weight gain (inc
Eintrag öffnenRxulti · 4.8 · 12 Weight gain In a short-term, controlled trial the percentage of subjects with clinically significant weight
Eintrag öffnenRxulti · 4.8 · 9 SOC Very common Common Uncommon Not known Immune system Rash Angioedema disorders Urticaria Swelling face
Eintrag öffnenRxulti · 4.8 · Adolescents aged 13 years and older with schizophrenia Frequency, type and severity of adverse reactions in ad
Eintrag öffnenRxulti · 4.8 · Adults Extrapyramidal Symptoms (EPS) Akathisia was the most frequently reported EPS related ADR in the brexpip
Eintrag öffnenRxulti · 4.8 · Akathisia From fixed -dose trials there appears to be a dose-response relationship for akathisia in patients t
Eintrag öffnenRxulti · 4.8 · Akathisia The incidence of akathisia in the brexpiprazole-treated paediatric subjects in a short-term, randomi
Eintrag öffnenRxulti · 4.8 · All ADRs are listed by system organ class (SOC) and frequency: very common (≥ 1/10), common (≥ 1/100 to < 1/10
Eintrag öffnenRxulti · 4.8 · Cardiac disorders Electrocardiogram QT prolonged
Eintrag öffnenRxulti · 4.8 · Description of selected adverse reactions
Eintrag öffnenRxulti · 4.8 · Extrapyramidal Symptoms (EPS) In short-term trials, akathisia was the most frequently reported EPS related ADR
Eintrag öffnenRxulti · 4.8 · Gastrointestinal Diarrhoea Dental caries disorders Nausea Flatulence Abdominal pain upper
Eintrag öffnenRxulti · 4.8 · In terms of gender differences, there were higher observed frequencies of nausea (4.8 % versus 2.8 %) and vomi
Eintrag öffnenRxulti · 4.8 · In the long-term, open-label trial, the percentage of subjects with clinically significant weight gain (increa
Eintrag öffnenRxulti · 4.8 · Metabolism and Weight nutrition disorders increase
Eintrag öffnenRxulti · 4.8 · Musculoskeletal and Back pain Myalgia Rhabdomyolysis connective tissue Pain in disorders extremity
Eintrag öffnenRxulti · 4.8 · Nausea For nausea, the incidence in the 2 mg to 4 mg brexpiprazole group was 2.3 % overall in short-term contr
Eintrag öffnenRxulti · 4.8 · Nausea TEAEs of Nausea have been reported in the adolescent schizophrenia trials. The safety profile observed
Eintrag öffnenRxulti · 4.8 · Nervous system Akathisia Parkinsonism Seizures disorders Dizziness Neuroleptic Tremor malignant Somnolence1 sy
Eintrag öffnenRxulti · 4.8 · Neuroleptic malignant syndrome A potentially fatal symptom complex referred to as Neuroleptic Malignant Syndro
Eintrag öffnen